Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trial

Peer Review reports

Original Submission
7 Jan 2020	Submitted	Original manuscript
13 Feb 2020	Reviewed	Reviewer Report - Rodolfo Gomez Ponce de Leon
14 Feb 2020	Reviewed	Reviewer Report - Joshua Vogel
13 Mar 2020	Author responded	Author comments - Daniele Barros Gattas
Resubmission - Version 2
13 Mar 2020	Submitted	Manuscript version 2
Publishing
27 Mar 2020	Editorially accepted
10 Apr 2020	Article published	10.1186/s12978-020-0901-8

Back to article page